Alzheimer's disease (AD) is a degenerative disease of the central nervous system
characterized by progressive cognitive and memory-related impairment. However, current …

Alzheimer's disease (AD) is a neurodegenerative disease of the central nervous system
characterised by cognitive impairment. Its major pathological feature is the deposition of β …

Alzheimer's disease (AD) is a common neurodegenerative disease, and its pathogenesis is
closely related to β-amyloid (Aβ) peptide. The deposition of Aβ in the brain due to impaired …

Microglial activation and neuroinflammation induced by amyloid β (Aβ) play pivotal roles in
Alzheimer's disease (AD) pathogenesis. Astragaloside IV (AS-IV) is one of the major active …

The inflammatory process plays a significant role in the pathophysiology of Alzheimer's
disease (AD). Anti-neuroinflammatory cascade is now considered an important measure for …

Rationale: Graphene oxide (GO) based nanomaterials have shown potential for the
diagnosis and treatment of amyloid-β (Aβ)-related diseases, mainly on Alzheimer's disease …

It is well established that overproduction and accumulation of the β-amyloid (Aβ) peptide 1–
42 (Aβ (1–42)) is a trigger of the pathological cascade in Alzheimer's disease (AD) that …

Alzheimer's disease (AD) is a neurodegenerative disorder imposing great threat to an
individual's cognitive capability. Mounting evidence suggests that type 2 diabetes mellitus …

Alzheimer's disease (AD) is a neurodegenerative disorder and the most relevant form of
dementia affecting people worldwide. AD was reported to be associated with increased …

Alzheimer's disease (AD) is the most common neurodegenerative disorder, tightly related
with microglia phenotypic polarization, which finally results in the stimulation of β-amyloid …